News Focus
News Focus
Followers 120
Posts 9723
Boards Moderated 0
Alias Born 02/03/2018

Re: skitahoe post# 542974

Saturday, 12/03/2022 7:01:56 PM

Saturday, December 03, 2022 7:01:56 PM

Post# of 822492
If NWBO earns the approval type described as agnostic, then theoretically, DCVAX - D could enjoy a near simultaneous approval for solid tumors. If true, shareholders could enjoy a top line valuation in an abbreviated timeline.

ILT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News